Participation in cancer clinical trials often suggests improved survival rates, but high-quality studies accounting for biases show no significant survival benefit. Trial benefits may be overstated due to confounding factors.
HHS Unveils Data Strategy to Fuel Cancer Moonshot
What You Should Know: – The U.S. Department of Health and Human Services (HHS) has released its comprehensive Data Strategy, outlining a vision for leveraging